Advertisement

The Latest

Volume of spine procedures, pushed down last year by reactions to prominent studies questioning the efficacy of some treatments, is expected to bounce back in 2011, according to Matthew O'Brien, an analyst at William Blair & Co. But Mr. O'Brien,…

MiMedx Group, a Marietta, Ga.-based manufacturer of biomaterial-based products, has completed the acquisition of Surgical Biologics, a development company focused on tissue-processing techniques for creating implants, according to a company news release.

Advertisement